Jheng-Yen Wu

67PUBLICATIONS
37CO-AUTHORS
Molecular targetsChild and adolescent developmentPharmacogenomicsRespiratory diseasesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Sep 21, 2026
Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes.

|Sep 14, 2026
Psychiatric Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adolescents With Obesity.

|Jul 17, 2026
Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

|Jul 10, 2026
Association Between Sacubitril/Valsartan Use and Risk of Major Adverse Cardiovascular Events in Patients With Durable Left Ventricular Assist Devices: A Multi-Institutional Real-World Cohort Study.

|Jul 08, 2026
Direct-Acting Antiviral Therapy and Long-Term Outcomes in Dialysis Patients With Hepatitis C: A Real-world Cohort Study.

|Jun 29, 2026
Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction.

Pageof 12

Frequent Collaborators

29 joint publications

Chih-Cheng Lai

17 joint publications

Po-Yu Huang

17 joint publications

Ya-Wen Tsai

15 joint publications

Kuo-Chuan Hung